These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23212356)

  • 1. [Current therapeutic options in retinopathy of prematurity].
    Krohne TU; Aisenbrey S; Holz FG
    Ophthalmologe; 2012 Dec; 109(12):1189-97. PubMed ID: 23212356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [VEGF antibodies as therapy for retinopathy of prematurity].
    Oberacher-Velten IM; Helbig H
    Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinopathy of prematurity - therapy. Part 2].
    Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
    Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laser treatment or intravitreal VEGF inhibition for aggressive posterior retinopathy of prematurity?].
    Barth T; Hufendiek K; Helbig H; Oberacher-Velten I
    Ophthalmologe; 2015 Jun; 112(6):520-4. PubMed ID: 25573085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinopathy of Prematurity - Update on Classification, Screening, and Therapy].
    Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):346-363. PubMed ID: 35253129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
    Kim J; Kim SJ; Chang YS; Park WS
    Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].
    Stahl A; Aisenbrey S; Krohne TU
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1024-9. PubMed ID: 22961043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
    Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.
    Lee JY; Chae JB; Yang SJ; Yoon YH; Kim JG
    Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
    Erol N; Gürsoy H; Sahin A; Basmak H
    J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.
    Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.
    Padhi TR; Das T; Kaur P; Sutar S; Khalsa A; Modi R; Ali H; Pradhan L; Jalali S
    Int Ophthalmol; 2020 Apr; 40(4):1007-1015. PubMed ID: 31925658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.
    Lepore D; Quinn GE; Molle F; Orazi L; Baldascino A; Ji MH; Sammartino M; Sbaraglia F; Ricci D; Mercuri E
    Ophthalmology; 2018 Feb; 125(2):218-226. PubMed ID: 28867130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
    Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
    J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic approaches in the treatment of retinopathy of prematurity].
    Jandeck C
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Solutions in Retinopathy of Prematurity.
    Moshfeghi DM
    Am J Ophthalmol; 2018 Sep; 193():xiv-xviii. PubMed ID: 29792838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.
    Moran S; O'Keefe M; Hartnett C; Lanigan B; Murphy J; Donoghue V
    Acta Ophthalmol; 2014 Sep; 92(6):e496-7. PubMed ID: 24428792
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
    Shah N; Gupta MP; Chan RVP
    JAMA Ophthalmol; 2018 Apr; 136(4):436-437. PubMed ID: 29285531
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
    Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
    Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.